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T R F - S T I M U L A T I O N - T E S T I N H Y P O T H A L A M I C A N D P I T U I T A R Y 
DISEASES, A N D I N A U T O N O M O U S A D E N O M A OF T H E T H Y R O I D 
C. R. Pickardt, F. Erhardt, W. Geiger, R. Fahlbusch, H. G. Heime 
and P. C. Scriba* 
Questions: 
1. What is the val id i ty of the TRF-stimulation test for the differentiation of 
hypothalamic and pi tui tary secondary hypothyroidism? 
2. What is the TSH-response to TRF-stimulation in patients w i t h „ autonomous 
adenoma" of the thyroid w i t h and without hyperthyroidism? 
Methods: 
500 ix% T R F was rapidly injected i . v . into hospitalized patients. Blood samples 
were wi thdrawn for T S H determinations before (—15 and —5 min) and after 
TRF-injection (5, 10, 20, 30, 60, 120 min and 24 h). Serum T S H levels were de-
termined radioimmunologically by a double antibody technique (1), using H T S H 
and a n t i - H T S H serum from N I H , Bethesda, and HTSH-Research Standard A 
from N I M R , London. 
Results: 
The TSH-response 30 min after injection of T R F was compared w i t h the 
integral of the TSH-response from zero up to 120 min. The use of the 120 min 
integral d id not improve differentiation between the groups as compared w i t h 
the 30 min value. 
The TSH-response after TRF-stimulation was absent or diminished in patients 
w i t h intrasellar tumors ( N = 12) after hypophysectomy, as compared to controls. 
I n 3 out of 9 patients w i t h intrasellar tumors studied preoperatively, secondary 
hypothyroidism existed. The TSH-response to T R F nevertheless was normal i n 
these 3 patients. This result decreases the value of the TRF-test for the differentia-
t ion of pi tui tary and hypothalamic secondary hypothyroidism. I n patients w i t h 
suprasellar tumors or hypothalamic diseases the TSH-response was above normal 
( N = 4), normal ( N = 2) or diminished ( N = 2). I n the latter 2 patients the an-
terior p i tu i tary was involved in the underlying disease. 
Further data obtained in patients w i t h acromegaly ( N = 13) and i n subjects w i t h 
autonomous adenoma of the thyro id w i l l be presented. 
1. Pickardt, C. R. et ai: K l i n . Wschr., i n pr in t . 
* Supported by the Deutsche Forschungsgemeinschaft (SFB 51). 
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